EPIDAREX CAPITAL III UK, LP
UK registered
Companies House number SL033678·9 UK shareholdings·1 ownership layers
EPIDAREX CAPITAL III UK, LP is a UK-registered corporate shareholder (Companies House number SL033678) and holds shares in 9 active UK companies, recorded across 23 share-class positions on their Companies House confirmation statements (CS01). Beneath those direct holdings OpenRegistry resolves a further 0 companies spanning 1 ownership layers; the persons-with-significant-control register independently agrees on 6 of these holdings. It ranks #1,870 of 54,210 corporate shareholders by number of active UK holdings. Programmatic access via MCP at https://openregistry.sophymarine.com/mcp.
Identity
UK company SL033678
Jurisdiction
UNITED KINGDOM
PSC register agrees on
6 holdings
Shareholdings
Every company EPIDAREX CAPITAL III UK, LP appears on as a member, as filed. 9 of 9 are linked to their Companies House profile.
| Company held | Status | Accounts | Share class | Shares | % of class | % of capital | Total % of capital | As of |
|---|
| MACOMICS LTDSC612928 | Active | SMALL | SERIES 3 SEED SHARES | 346,088 | 43.49% | 20.01% | 38.99% | 2025-11-05 |
| SERIES 2 SEED SHARES | 187,617 | 55.06% | 10.85% |
| SERIES 1 SEED SHARES | 140,713 | 55.06% | 8.13% |
| CURVE THERAPEUTICS LIMITED11989962 | Active | SMALL | SERIES A-2 PREFERRED | 2,471,315 | 9.88% | 7.74% | 14.79% | 2026-05-09 |
| SERIES A PREFERRED | 2,250,000 | 50.00% | 7.05% |
| THEOLYTICS LTD11001290 | Active | SMALL | SERIES A | 6,451 | 26.55% | 4.32% | 10.84% | 2025-10-05 |
| SERIES A-1 | 5,161 | 6.08% | 3.46% |
| SERIES A-2 | 4,579 | 28.50% | 3.07% |
| LEUCID BIO LTD09331486 | Active | | SEED PARTICIPATING PREFERENCE | 500,000 | | | | 2025-11-27 |
| SERIES A PREFERRED | 957,188 | | |
| SERIES A1 PREFERRED | 3,613,829 | | |
| EPSILOGEN LTD10295520 | Active | FULL | SERIES A2 | 2,363,636 | | | | 2025-07-25 |
| SERIES B | 6,260,746 | | |
| ORDINARY | 2,411,964 | | |
| HARNESS THERAPEUTICS LIMITED11532498 | Active | SMALL | PREFERRED | 2,647 | | | | 2024-08-21 |
| ORDINARY | 447 | | |
| DUNAD THERAPEUTICS LTD.12544797 | Active | | SERIES B3 | 4,782,610 | | | | 2026-04-01 |
| SERIES A1 | 13,230,440 | | |
| SERIES B2 | 7,608,695 | | |
| SERIES B1 | 2,218,573 | | |
| EPIDAREX EXEED LIMITEDSC639047 | Active | | PREFERRED | 6,761,008 | | | | 2022-09-02 |
| LARIO THERAPEUTICS LIMITEDSC716204 | Active | | SERIES SEED PREFERRED | 100,000 | | | | 2025-11-25 |
| SERIES A | 186,534 | | |
Related company owners
Corporate shareholders that hold shares in the same UK companies as EPIDAREX CAPITAL III UK, LP:
Other corporate shareholders of comparable size registered in UNITED KINGDOM:
Need the registered office, SIC code, accounts and filing history for EPIDAREX CAPITAL III UK, LP? Open its Companies House profile at https://openregistry.sophymarine.com/insights/gb/SL033678-epidarex-capital-iii-uk-lp.